What question did this study set out to answer?

This guideline aims to update recommendations for the prevention, diagnosis, and treatment of respiratory virus infections in cancer patients.

January 23, 2026Annals of HematologyOpen Access

Prevention, diagnosis and management of community acquired respiratory virus infections including COVID-19 in patients with cancer: 2025 updated evidence-based guideline of the infectious diseases working party (AGIHO) of the German society for hematology and medical oncology (DGHO)

View Full Paper

Ask AI

Bookmark

Authors

NGNicola GiesenRobert Bosch Hospital SMSibylle C. MellinghoffUniversity of Cologne EKElham KhatamzasHeidelberg University

Discussion

Member takes

Implication

Guidelines provide evidence-based strategies for managing respiratory virus infections in immunocompromised cancer patients, highlighting important preventive measures.

Key Points

This guideline aims to update recommendations for the prevention, diagnosis, and treatment of respiratory virus infections in cancer patients.
Systematic review of available data on respiratory viruses in cancer patients
Guideline development by an expert panel from AGIHO
Focus on immunocompromised patients, including those with solid tumors and hematologic malignancies
Identification of critical strategies for prevention and early treatment of infections
Emphasis on the unique risks posed by SARS-CoV-2 in cancer patients
Updated recommendations to enhance clinical care for vulnerable populations

Cite This Study

Giesen et al. (2026) studied this question.

synapsesocial.com/papers/69731089c8125b09b0d203f7 https://doi.org/10.1007/s00277-026-06769-9

View Full Paper

Ask AI

Bookmark

Implication

Guidelines provide evidence-based strategies for managing respiratory virus infections in immunocompromised cancer patients, highlighting important preventive measures.

Prevention, diagnosis and management of community acquired respiratory virus infections including COVID-19 in patients with cancer: 2025 updated evidence-based guideline of the infectious diseases working party (AGIHO) of the German society for hematology and medical oncology (DGHO)

Discussion

Member takes

Implication

Key Points

Cite This Study

Prevention, diagnosis and management of community acquired respiratory virus infections including COVID-19 in patients with cancer: 2025 updated evidence-based guideline of the infectious diseases working party (AGIHO) of the German society for hematology and medical oncology (DGHO)

Discussion

Member takes

Implication

Key Points

Cite This Study

Also Consider

Also Consider